Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy.

Ye X, Bo X, Hu X, Cui H, Lu B, Shao J, Wang J

DOI: 10.1111/cen.13170
Published: 2017 Feb
Container: Clinical endocrinology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cen.13170,
  title = {Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy.},
  author = {Ye X and Bo X and Hu X and Cui H and Lu B and Shao J and Wang J},
  year = {2017},
  journal = {Clinical endocrinology},
  doi = {10.1111/cen.13170},
  url = {https://doi.org/10.1111/cen.13170}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy.
AU  - Ye X
AU  - Bo X
AU  - Hu X
AU  - Cui H
AU  - Lu B
AU  - Shao J
AU  - Wang J
PY  - 2017
JO  - Clinical endocrinology
DO  - 10.1111/cen.13170
UR  - https://doi.org/10.1111/cen.13170
ER  -

APA

X, Y., X, B., X, H., H, C., B, L., J, S., & J, W. (2017). Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy.. Clinical endocrinology. https://doi.org/10.1111/cen.13170

Source records

pubmed · retrieved 2026-09-25T04:49:16.503Z